Literature DB >> 24338243

Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.

Deborah R Gustafson1, Michelle M Mielke, Phyllis C Tien, Victor Valcour, Mardge Cohen, Kathryn Anastos, Chenglong Liu, Leigh Pearce, Elizabeth T Golub, Howard Minkoff, Howard A Crystal.   

Abstract

This study aimed to explore the relationship of body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) with cognition in women with (HIV+) and without HIV (HIV-) infection. One thousand six hundred ninety participants (1,196 HIV+, 494 HIV-) in the Women's Interagency HIV Study (WIHS) with data available on anthropometric measures comprise the analytical sample. Cross-sectional analyses using linear regression models estimated the relationship between anthropometric variables and Trails A, Trails B, Stroop interference time, Stroop word recall, Stroop color naming and reading, and Symbol Digit Modalities Test (SDMT) with consideration for age, HIV infection status, Wide Range Achievement Test score, CD4 count, insulin resistance, drug use, and race/ethnicity. Among HIV+ women, BMI < 18.5 kg/m(2) was associated with poorer cognitive performance evidenced by longer Trails A and Trails B and shorter SDMT completion times. An obese BMI (30 kg/m(2) or higher) was related to better performance on Trails B and worse performance on the Stroop interference test. Among HIV- women, an obese BMI was related to worse performance on the Stroop color naming test. Few and inconsistent associations were observed between WC, WHR, and cognition. Among women at mid-life with chronic (at least 10 years) HIV infection, common anthropometric measures, primarily BMI, were differentially related to cognitive test performance by cognitive domain. Higher levels of BMI were associated with better cognitive function. In this era of antiretroviral therapies, restoration of health evidenced as higher BMI due to effective antiretroviral therapies, may improve cognitive function in middle-aged HIV-infected women.

Entities:  

Mesh:

Year:  2013        PMID: 24338243      PMCID: PMC3957488          DOI: 10.1007/s13365-013-0219-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  36 in total

1.  An international screening tool for HIV dementia.

Authors:  Joseph R Berger; Bruce Brew
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Fat distribution in women with HIV infection.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

4.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

5.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

6.  Body mass index in midlife and risk of Alzheimer disease and vascular dementia.

Authors:  Rachel A Whitmer; Erica P Gunderson; Charles P Quesenberry; Jufen Zhou; Kristine Yaffe
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

9.  Waist-to-hip ratio in a biracial population: measurement, implications, and cautions for using guidelines to define high risk for cardiovascular disease.

Authors:  J B Croft; N L Keenan; D P Sheridan; F C Wheeler; M A Speers
Journal:  J Am Diet Assoc       Date:  1995-01

10.  Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin.

Authors:  Nirav R Shah; Eric R Braverman
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more
  13 in total

Review 1.  Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study.

Authors:  David E Vance; Leah H Rubin; Victor Valcour; Drenna Waldrop-Valverde; Pauline M Maki
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

2.  Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.

Authors:  Elizabeth C Pasipanodya; Jessica L Montoya; Laura M Campbell; Mariam A Hussain; Rowan Saloner; Emily M Paolillo; Dilip V Jeste; Scott L Letendre; J Allen McCutchan; Robert K Heaton; David J Moore
Journal:  Arch Clin Neuropsychol       Date:  2021-02-12       Impact factor: 2.813

3.  Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria.

Authors:  Jibreel Jumare; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Anya Umlauf; Donald Franklin; Manisha Ghate; Alashʼle Abimiku; Man Charurat; Scott Letendre; Ronald J Ellis; Sanjay Mehendale; William A Blattner; Walter Royal; Thomas D Marcotte; Robert K Heaton; Igor Grant; John A McCutchan
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

Review 4.  Microvascular Function in Aging Among Women Living with HIV.

Authors:  Jean-Jacques Monsuez; Catherine Belin; Olivier Bouchaud
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

5.  Leptin, Adiponectin and Cognition in Middle-aged HIV-infected and Uninfected Women. The Brooklyn Women's Interagency HIV Study.

Authors:  Deborah R Gustafson; Michelle M Mielke; Sheila A Keating; Susan Holman; Howard Minkoff; Howard A Crystal
Journal:  J Gerontol Geriatr Res       Date:  2015-09-23

6.  Sex differences in neurocognitive screening among adults living with HIV in China.

Authors:  Xiaotong Qiao; Haijiang Lin; Xiaoxiao Chen; Chenxi Ning; Keran Wang; Weiwei Shen; Xiaohui Xu; Xiaoyi Xu; Xing Liu; Na He; Yingying Ding
Journal:  J Neurovirol       Date:  2019-02-13       Impact factor: 2.643

7.  Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.

Authors:  Chukwuemeka N Okafor; Natalie E Kelso; Vaughn Bryant; Larry E Burrell; Maria Jose Míguez; Assawin Gongvatana; Karen T Tashima; Suzanne de la Monte; Robert L Cook; Ronald A Cohen
Journal:  Psychol Health Med       Date:  2016-06-20       Impact factor: 2.423

8.  Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.

Authors:  Samy I McFarlane; Michelle M Mielke; Anthony Uglialoro; Sheila M Keating; Susan Holman; Howard Minkoff; Howard A Crystal; Deborah R Gustafson
Journal:  J Neurol Neurophysiol       Date:  2017-02-08

9.  Epidemiology Informs Randomized Clinical Trials of Cognitive Impairments and Late-Onset, Sporadic Dementias.

Authors:  Deborah R Gustafson
Journal:  J Neurol Neuromedicine       Date:  2018

10.  Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV.

Authors:  Francesca Macaluso; Deborah R Gustafson
Journal:  J AIDS HIV Treat       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.